Loading clinical trials...

COMPLETEDNA

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Acupuncture For Prevention Of Postoperative Nausea And Vomiting In Patients Undergoing Laparoscopic Cholecystectomy - A Randomized Controlled Trial

NCT05975385•Baylor College of Medicine

View on ClinicalTrials.gov

Summary

The purpose is to find out if intraoperative acupuncture performed by needling PC 6 and LI4 point bilaterally, and Yin Tang point will help reduce the incidence postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when added to a prophylactic regimen consisting of ondansetron and dexamethasone. The hypothesis is that the addition of this acupuncture treatment to ondansetron and dexamethasone given for prophylaxis will help reduce the incidence of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy when compared to patients receiving ondansetron and dexamethasone without acupuncture.

Eligibility

Age

18 - 64 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Patient ages 18-64
•2. American Society of Anesthesiology Physical Status I, II or III
•3. Patients scheduled to undergo laparoscopic cholecystectomy at Harris Health System Ben Taub Hospital

Exclusion Criteria

•1. Scheduled open cholecystectomy - excluded due to increased levels of pain in open procedures
•2. Renal dysfunction (Serum Cr \> 1.2) - excluded due to potential altered metabolism of anesthetic and perioperative medications
•3. Allergy to any of the standard anesthetic agents
•4. Patient inability to properly communicate with investigators (language barrier, dementia, delirium, psychiatric disorder)
•5. Patient or surgeon refusal

Locations (1)

Ben Taub Hospital

Houston, Texas, United States

Key Dates

Start Date

October 9, 2023

Primary Completion Date

January 16, 2026

Completion Date

February 10, 2026

Last Updated

March 3, 2026

Enrollment

270

ACTUAL participants

Conditions

Cholecystitis, AcuteCholelithiasisNausea, PostoperativeVomiting, PostoperativePain, Postoperative

Interventions

Acupuncture

DEVICE

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

NCT07005752

Cholesterol Cholelithiasis

View study

RECRUITINGNA

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

NCT06123117

CholelithiasisCholecystitis+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Acupuncture for Prevention of Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy

Inclusion Criteria

Exclusion Criteria

A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones).

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study

Optimal Timing for Laparoscopic Cholecystectomy After Cholecystostomy in Acute Cholecystitis Tokyo II/III Setting

Effects of Local Ketamine in Orthognathic Procedures

Effect of Erector Spinae Plane Block on Postoperative Respiratory Function After Laparoscopic Cholecystectomy